Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.
about
Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIVDetectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho StudyMaternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.The impact of African ethnicity and migration on pregnancy in women living with HIV in the UK: design and methodsPredictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.Dramatic decline in substance use by HIV-infected pregnant women in the United States from 1990 to 2012Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort studySubstance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.Validation of the Gen-Probe Aptima qualitative HIV-1 RNA assay for diagnosis of human immunodeficiency virus infection in infants.Pregnancy and linkage to care among women diagnosed with HIV infection in 61 CDC-funded health departments in the United States, 2013.Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
P2860
Q28546081-ACA46834-52A8-45A5-81E7-60FC14817FDCQ28555187-2D7526A2-9269-49B5-ADBE-FC5FD183C1ECQ33825735-EAC0024D-748C-4A84-B2EF-BD3F2472A42AQ34310482-BAD4FD07-29BA-456F-91A8-CCE611E1BC34Q34361658-EAFD69D6-00E2-4D77-B792-1CCF20FDC7AAQ34649171-25517156-411F-4F43-85BF-F087E4C3AE86Q34849220-C91751A9-33DA-47EC-AAE3-6053BE2DEB32Q34988296-62B7BCC3-CE40-4CBB-AD23-58628ADBF831Q34992602-6CEEB20D-C1AB-4623-950B-B30E3672A9C8Q35869263-8EC2106F-2242-416B-95FE-F1042A313FE7Q36438846-843E3A42-450C-4F05-BF6C-F18FA06C8B39Q37336329-3A88E8A2-6601-4AFB-8B32-A4FCCA1AD7F5Q38993301-59CE6612-9492-4FC4-906C-E5A16742F8DCQ42318291-138AE393-F765-4FA2-B161-D12BE977739AQ52577900-D1BCDA13-E370-4997-AC99-E0EBE80D20E1
P2860
Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk factors for detectable HI ...... nd infants transmission study.
@ast
Risk factors for detectable HI ...... nd infants transmission study.
@en
type
label
Risk factors for detectable HI ...... nd infants transmission study.
@ast
Risk factors for detectable HI ...... nd infants transmission study.
@en
prefLabel
Risk factors for detectable HI ...... nd infants transmission study.
@ast
Risk factors for detectable HI ...... nd infants transmission study.
@en
P2093
P2860
P1476
Risk factors for detectable HI ...... nd infants transmission study.
@en
P2093
Bruce Thompson
D Heather Watts
Michael D Hughes
Roger Shapiro
Ruth Tuomala
P2860
P356
10.1097/QAI.0B013E3181CAEA89
P407
P577
2010-05-01T00:00:00Z